BiotechTube
Home/Hepion Pharmaceuticals/Timothy M. Block, Ph.D.
TM

Timothy M. Block, Ph.D.

Director

Hepion Pharmaceuticals

Therapeutic Areas

OncologyHepatology

Hepion Pharmaceuticals Pipeline

DrugIndicationPhase
mSEPT9 DNA Biomarker TestEarly Detection & Surveillance of Hepatocellular Carcinoma (HCC) in CirrhosisPre-commercial
ctRNA Biomarker AssayEarly Diagnosis & Surveillance of Hepatocellular Carcinoma (HCC)Assay Development

Leadership Team at Hepion Pharmaceuticals

DK
Dr. Kaouthar Lbiati
Interim Chief Executive Officer
MP
Michael Purcell
Board Chair
View full Hepion Pharmaceuticals profile